Evidence-Based Development and Rationale for Once-Daily Rivaroxaban Dosing Regimens Across Multiple Indications.
about
Evidence-Based Development and Rationale for Once-Daily Rivaroxaban Dosing Regimens Across Multiple Indications.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Evidence-Based Development and ...... s Across Multiple Indications.
@en
type
label
Evidence-Based Development and ...... s Across Multiple Indications.
@en
prefLabel
Evidence-Based Development and ...... s Across Multiple Indications.
@en
P2860
P356
P1476
Evidence-Based Development and ...... ns Across Multiple Indications
@en
P2093
Dagmar Kubitza
Frank Misselwitz
P2860
P304
P356
10.1177/1076029616631427
P577
2016-02-18T00:00:00Z